Repligen Corporation to Present at Upcoming November Conferences
WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending five upcoming investor conferences. The UBS Global Healthcare Conference, being held November 10 – 12 in Palm Beach Gardens, FL. Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion at 11:00 a.m. ET on Monday, November 10. The Stifel Healthcare Conference, being held November 11 – 13 in New York. Olivier Loeillot, President and Chief Executive Officer, will participate in an analyst-led discussion at 10:00 a.m. ET on Tuesday, November 11. The Wolfe Research Healthcare Conference, being held November 17 – 19 in New York. Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion at 12:40 p.m. ET on Tuesday, November 18. The Jefferies Global Healthcare Conference, being held November 18 – 20 in London, UK. Olivier Loeillot,
